Working to Overcome Antibiotic Resistance Program Aims to Trump Overuse of Antibiotics
With its new Antimicrobial Stewardship Program, the Penn State Health St. Joseph pharmacy has created a multi-disciplinary team focused on curtailing the routine-and oftentimes uncalled for-use of antimicrobial agents – known to most people as antibiotics. It is one way St. Joe’s is working to address the concern for a growing number of patients who are resistant to these bacteria fighting medications.
The stewardship group was founded in August and is led by Evan Slagle, PharmD, BCPS, St. Joe’s Antimicrobial Stewardship Pharmacist. Physician oversight of the program is being provided by Infectious Disease Specialist Dr. Deb Powell.
Slagle says the group’s objective is to develop strategies to work on the optimal selection, dosage and duration of antimicrobials within St. Joseph.
He says antibiotic resistance is growing faster than the new drugs becoming available. And, as resistance grows, meaning antibiotics are not the effective treatment for some people they used to be, it can lead to severe consequences including higher mortality rates, increased lengths of stay and growing costs of care.
Slagle noted the Center for Medicare and Medicaid Services, the Centers for Disease Control and the Food and Drug administration, as well as Congress and the White House also are advising and monitoring how the healthcare system is addressing the issue.
Slagle is working with the stewardship group and caregivers on a number of pharmacy driven initiatives which are in place, and others will be coming, he added.
“Most of the immediate focus of our group has been to make sure we are meeting the stewardship standards of our accreditation/regulatory agencies,” says Slagle. “Our infection rates have been very good. Many of the strategies we have been enforcing are supporting this positive trend.”